<DOC>
	<DOCNO>NCT02945982</DOCNO>
	<brief_summary>Portal hypertension common pathology chronic liver disease , particularly liver cirrhosis . Hepatitis B Virus ( HBV ) one etiologies liver cirrhosis China . The basic reason portal hypertension HBV largely deposition hepatic extracellular matrix cause high pressure liver vessel . One common symptom cirrhotic portal hypertension gastroesophageal varices.The effective inhibition HBV partially stop reverse liver fibrosis patient chronic Hepatitis liver cirrhosis due HBV anti-fibrotic strategy focus regulation hepatic extracellular matrix may great benefit . Therefore , antiviral therapy also basic treatment low-grade cirrhotic portal hypertension . Fuzheng Huayu find enhance degradation collagens fibrotic liver good action liver fibrosis patient chronic hepatitis B . However , high quality clinical evidence demonstrate combination anti-viral anti-fibrotic therapy relieve pressure liver vessel decline incidence rate bleed rate gastroesophageal varix .</brief_summary>
	<brief_title>Treatment Moderate Severe Cirrhotic Portal Hypertension Due HBV With Traditional Chinese Medicine Entecavir</brief_title>
	<detailed_description>The primary objective study establish safety efficacy combination Entecavir Fuzheng Huayu reverse rate gastroesophageal varix patient Moderate Severe cirrhotic portal hypertension due hepatitis B virus .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Portal</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Entecavir</mesh_term>
	<criteria>More 6 month history serum positive HBsAg Abdominal ultrasonogram CT scan liverbiopsy specimen indicate liver cirrhosis Age 1865 ChildPugh &lt; 7 ( Stage A ) Without portal hypertension（Endoscopy indicate sign gastroesophageal varices.） Moderate Severe portal hypertension（Endoscopy indicate sign gastroesophageal varix line shape without red wale spots less 0.3cm diameter.） The patient patient 's guardian agree participate random control trial sign Informed Consent Form . Primary Lamivudine , Adefovir dipivoxil Entecavir resistance Decompensated cirrhosis、The ChildPugh score≥7 Lowgrade Cirrhotic Portal Hypertension . Severe grade portal hypertension（Endoscopy indicate sign gastroesophageal varix catenulate/nodular shape without red wale spot 1.0cm diameter.） Decompensated liver cirrhosis Liver cancer Liver histology conform chronic liver disease cause ( exclude fatty liver ) NonHBV avihepadnavirus infect acute chronic hepatitis , autoimmune hepatitis , primary biliary cirrhosis , primary sclerosing cholangitis , inherit metabolic liver disease , drug toxic hepatitis , Alcoholic liver disease . Have psychiatric history uncontrollable epilepsy patient . Uncontrollable diabetic patient History Hemoglobin disease ( Alpha globin generation barrier anemia , Sickle cell deficiency , Spherocytosis ) Hemolytic anemia patient cause reason like autoimmunity . Severe background disease like chronic respiratory failure , circulatory failure , kidney failure etc . In situ organ transplantation ( liver , kidney , lung heart ) bone marrow transplantation stem cell transplantation . Immunocompromised patient : HIV infection take immunosuppressor glucocorticoid ( cyclosporin , azathioprine , adrenocortical hormone ) within 3 month chemotherapy drug ( cyclophosphamide , ammonia cancer chemotherapy ) radioactive therapy . Gestation lactation period woman woman plan get pregnant study period . Patient allergy experimental drug . Using history antiviral antifibrosis drug within 6 month . Patients participate trial . Other situation PI think patient exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Portal Hypertension</keyword>
	<keyword>Fuzheng Huayu</keyword>
	<keyword>Hepatitis B</keyword>
</DOC>